Hong Cen

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

Yuankai Shi, Jianqiu Wu, Zhen Wang et al. · Journal of Hematology & Oncology · 2021 · 62 citations · Full text

TGF-β1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression

Haibo Mou, Maofang Lin, Hong Cen et al. · Journal of Zhejiang University. Science A · 2004 · 26 citations · Full text

Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.

Weili Zhao, Jun Zhu, Yuqin Song et al. · Journal of Clinical Oncology · 2024 · 12 citations

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy

Zhe Li, Ying Duan, Qing Ke et al. · Frontiers in Genetics · 2022 · 11 citations · Full text